PSORIASIS (PSO)
Clinical trials for PSORIASIS (PSO) explained in plain language.
Never miss a new study
Get alerted when new PSORIASIS (PSO) trials appear
Sign up with your email to follow new studies for PSORIASIS (PSO), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for psoriasis sufferers: Long-Term drug study underway
Disease control OngoingThis study looks at the long-term safety and effectiveness of the drug ESK-001 for people with moderate to severe plaque psoriasis. About 1,680 adults who have already been in a prior ESK-001 study will take the drug for 24 weeks, then some may switch to a placebo to see how well…
Matched conditions: PSORIASIS (PSO)
Phase: PHASE3 • Sponsor: Alumis Inc • Aim: Disease control
Last updated May 17, 2026 02:26 UTC
-
Liver-Psoriasis link study pulled before starting
Knowledge-focused TerminatedThis study was designed to see if there is a connection between non-alcoholic fatty liver disease (NAFLD) and psoriatic disease (psoriasis and psoriatic arthritis). It planned to give guselkumab, an FDA-approved drug for psoriatic disease, to overweight adults with both condition…
Matched conditions: PSORIASIS (PSO)
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated May 17, 2026 02:27 UTC
-
Doctor education aims to boost use of cheaper biologic drugs
Knowledge-focused OngoingThis study tests whether offering doctors one-on-one educational meetings about biosimilar medications leads them to prescribe more biosimilars instead of the original brand-name drugs. About 1,325 clinicians who prescribe adalimumab will be randomly offered either an in-person o…
Matched conditions: PSORIASIS (PSO)
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 07, 2026 18:39 UTC